Azoramide - 98%, high purity , CAS No.932986-18-0

1 Citations
  • ≥98%
Item Number
A195910
Grouped product items
SKUSizeAvailabilityPrice Qty
A195910-25mg
25mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$129.90
A195910-100mg
100mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$380.90

Discover Azoramide by Aladdin Scientific in 98% for only $129.90. Available - in Ligands at Aladdin Scientific. Unfolded protein response (UPR) modulator Tags: .

Basic Description

SynonymsCCG-267569 | BRD-K67416388-001-01-3 | N-[2-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]ethyl]butanamide | SCHEMBL21523880 | Azoramide, >=98% (HPLC) | NCGC00484058-03 | s8304 | BCP23896 | NCGC00484058-01 | CS-4954 | N-{2-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]ethyl
Specifications & Purity≥98%
Shipped InNormal

Names and Identifiers

IUPAC Name N-[2-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]ethyl]butanamide
INCHI InChI=1S/C15H17ClN2OS/c1-2-3-14(19)17-9-8-13-10-20-15(18-13)11-4-6-12(16)7-5-11/h4-7,10H,2-3,8-9H2,1H3,(H,17,19)
InChi Key VYBFWKKCWTXCQX-UHFFFAOYSA-N
Canonical SMILES CCCC(=O)NCCC1=CSC(=N1)C2=CC=C(C=C2)Cl
Isomeric SMILES CCCC(=O)NCCC1=CSC(=N1)C2=CC=C(C=C2)Cl
PubChem CID 7518316
Molecular Weight 308.83

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

2 results found

Lot NumberCertificate TypeDateItem
J1823106Certificate of AnalysisMay 10, 2024 A195910
J1823105Certificate of AnalysisMay 10, 2024 A195910

Chemical and Physical Properties

SolubilitySolvent:DMSO, Max Conc. mg/mL: 30.88, Max Conc. mM: 100; Solvent:ethanol, Max Conc. mg/mL: 30.88, Max Conc. mM: 100

Related Documents

Citations of This Product

1. Fengying Dai, Kepeng Lv, Bo Zhang, Junqiang Zhao, Shaoteng Wang, Ke Lan, Yiping Zhao, Xiaolei Zhang, Bohong Kan.  (2023)  Overcoming the structure deficiency of nanodrug coated with tannic acid shell through phenolic hydroxyl protection strategy for Alzheimer's disease combination treatment.  Biomaterials Advances,  154  (21): (213651).  [PMID:37827021]

References

1. Fengying Dai, Kepeng Lv, Bo Zhang, Junqiang Zhao, Shaoteng Wang, Ke Lan, Yiping Zhao, Xiaolei Zhang, Bohong Kan.  (2023)  Overcoming the structure deficiency of nanodrug coated with tannic acid shell through phenolic hydroxyl protection strategy for Alzheimer's disease combination treatment.  Biomaterials Advances,  154  (21): (213651).  [PMID:37827021]

Solution Calculators